Skip to main content
Journal cover image

Concordance and frequency of TP53 protein expression and gene sequence in mismatch repair proficient (pMMR) and POLE wild-type endometrial cancer: An endometrial cancer molecularly targeted therapy consortium (ECMT2) database study

Publication ,  Conference
Vue, N; Miller, E; Secord, AA; Krivak, T; Crafton, S; Nakayama, J; Morse, C; Wield, A; Horne, Z; Zimmerman, J; Yin, Y; Linhart, S; Arend, R ...
Published in: Gynecologic Oncology
September 2025

Duke Scholars

Published In

Gynecologic Oncology

DOI

ISSN

0090-8258

Publication Date

September 2025

Volume

200

Start / End Page

S2 / S3

Publisher

Elsevier BV

Related Subject Headings

  • Oncology & Carcinogenesis
  • 3215 Reproductive medicine
  • 3211 Oncology and carcinogenesis
  • 3202 Clinical sciences
  • 1114 Paediatrics and Reproductive Medicine
  • 1112 Oncology and Carcinogenesis
 

Citation

APA
Chicago
ICMJE
MLA
NLM
Vue, N., Miller, E., Secord, A. A., Krivak, T., Crafton, S., Nakayama, J., … Hacker, K. (2025). Concordance and frequency of TP53 protein expression and gene sequence in mismatch repair proficient (pMMR) and POLE wild-type endometrial cancer: An endometrial cancer molecularly targeted therapy consortium (ECMT2) database study. In Gynecologic Oncology (Vol. 200, pp. S2–S3). Elsevier BV. https://doi.org/10.1016/j.ygyno.2025.04.522
Vue, Nujsaubnusi, Eirwen Miller, Angeles Alvarez Secord, Thomas Krivak, Sarah Crafton, John Nakayama, Christopher Morse, et al. “Concordance and frequency of TP53 protein expression and gene sequence in mismatch repair proficient (pMMR) and POLE wild-type endometrial cancer: An endometrial cancer molecularly targeted therapy consortium (ECMT2) database study.” In Gynecologic Oncology, 200:S2–3. Elsevier BV, 2025. https://doi.org/10.1016/j.ygyno.2025.04.522.
Vue N, Miller E, Secord AA, Krivak T, Crafton S, Nakayama J, Morse C, Wield A, Horne Z, Zimmerman J, Yin Y, Linhart S, Arend R, Toboni M, Washington C, Cosgrove C, Haight P, Pothuri B, Hacker K. Concordance and frequency of TP53 protein expression and gene sequence in mismatch repair proficient (pMMR) and POLE wild-type endometrial cancer: An endometrial cancer molecularly targeted therapy consortium (ECMT2) database study. Gynecologic Oncology. Elsevier BV; 2025. p. S2–S3.
Journal cover image

Published In

Gynecologic Oncology

DOI

ISSN

0090-8258

Publication Date

September 2025

Volume

200

Start / End Page

S2 / S3

Publisher

Elsevier BV

Related Subject Headings

  • Oncology & Carcinogenesis
  • 3215 Reproductive medicine
  • 3211 Oncology and carcinogenesis
  • 3202 Clinical sciences
  • 1114 Paediatrics and Reproductive Medicine
  • 1112 Oncology and Carcinogenesis